Jornal Vascular Brasileiro
https://app.periodikos.com.br/journal/jvb/article/doi/10.1590/1677-5449.007915
Jornal Vascular Brasileiro
Editorial

O tratamento atual da hiperhidrose

Current treatment of hyperhidrosis

Nelson Wolosker, Juliana Maria Fukuda

Downloads: 1
Views: 1190


References

1. Lear W, Kessler E, Solish N, Glaser DA. An epidemiological study of hyperhidrosis. Dermatol Surg. 2007;33(1 Spec No.):S69-75. http:// dx.doi.org/10.1111/j.1524-4725.2006.32334.x. PMid:17241417.

2. Campos JRM, Kauffman P, Werebe EC, et al. Quality of life, before and after thoracic sympathectomy: report on 378 operated patients. Ann Thorac Surg. 2003;76(3):886-91. http://dx.doi.org/10.1016/ S0003-4975(03)00895-6. PMid:12963223.

3. Bushara KO, Park DM, Jones JC, Schutta HS. Botulinum toxin: a possible new treatment for axillary hyperhidrosis. Clin Exp Dermatol. 1996;21(4):276-8. http://dx.doi.org/10.1111/j.1365-2230.1996. tb00093.x. PMid:8959898.

4. LeWitt P. Hyperhidrosis and hypothermia responsive to oxybutynin. Neurology. 1988;38(3):506-7. http://dx.doi.org/10.1212/ WNL.38.3.506-a. PMid:3347362.

5. Wolosker N, Campos JR, Kauffman P,  et  al. An alternative to treat palmar hyperhidrosis: use of oxybutynin. Clin Auton Res. 2011;21(6):389-93. http://dx.doi.org/10.1007/s10286-011-0128-4. PMid:21688168.

6. Wolosker N, Campos JRM, Kauffman P, Yazbek G, Neves S, PuechLeão P. Use of oxybutynin for treating plantar hyperhidrosis. Int J Dermatol. 2013;52(5):620-3. http://dx.doi.org/10.1111/j.1365- 4632.2012.05746.x. PMid:23590378.

7. Wolosker N, Campos JRM, Kauffman P, et al. The use of oxybutynin for treating axillary hyperhidrosis. Ann Vasc Surg. 2011;25(8):1057- 62. http://dx.doi.org/10.1016/j.avsg.2011.06.007. PMid:22023940.

8. Wolosker N, Campos JRM, Kauffman P, et al. The use of oxybutynin for treating facial hyperhidrosis. An Bras Dermatol. 2011;86(3):451-6. http://dx.doi.org/10.1590/S0365-05962011000300005. PMid:21738960.

9. Wolosker N, Teivelis MP, Krutman M, et al. Long-term results of oxybutynin treatment for palmar hyperhidrosis. Clin Auton Res. 2014;24(6):297-303. http://dx.doi.org/10.1007/s10286-014-0264-8. PMid:25427685.

10. Wolosker N, Teivelis MP, Krutman M, et al. Long-term results of the use of oxybutynin for the treatment of plantar hyperhidrosis. Int J Dermatol. 2015;54(5):605-11. http://dx.doi.org/10.1111/ ijd.12729. PMid:25600990.

11. Wolosker N, Teivelis MP, Krutman M, et al. Long-term results of the use of oxybutynin for the treatment of axillary hyperhidrosis. Ann Vasc Surg. 2014;28(5):1106-12. http://dx.doi.org/10.1016/j. avsg.2013.12.024. PMid:24512855.

12. Wolosker N, Teivelis MP, Krutman M, et al. Long-term results of oxybutynin use in treating facial hyperhidrosis. An Bras Dermatol. 2014;89(6):912-6. http://dx.doi.org/10.1590/abd1806-4841.20143272. PMid:25387496.

13. Yoshida WB, Cataneo DC, Bomfim GAZ, Hasimoto E, Cataneo AJM. Chemical lumbar sympathectomy in plantar hyperhidrosis. Clin Auton Res. 2010;20(2):113-5. http://dx.doi.org/10.1007/ s10286-009-0047-9. PMid:20012143.

14. Wolosker N, Campos JRM, Kauffman P, Oliveira LA, Munia MAS, Jatene FB. Evaluation of quality of life over time among 453 patients with hyperhidrosis submitted to endoscopic thoracic sympathectomy. J Vasc Surg. 2012;55(1):154-6. http://dx.doi. org/10.1016/j.jvs.2011.07.097. PMid:22047833.

15. Kux E. 1239 Cases of thorascopic sympathectomy and vagotomy; preliminary report. Dtsch Med Wochenschr. 1953;78(46):1590-2. http://dx.doi.org/10.1055/s-0028-1115011. PMid:13107399.

16. Andrade LO Fo, Kuzniec S, Wolosker N, Yazbek G, Kauffman P, Campos JRM. Technical difficulties and complications of sympathectomy in the treatment of hyperhidrosis: an analysis J Vasc Bras. 2015 Oct.-Dec.; 14(4):279-281 281 Nelson Wolosker, Juliana Maria Fukuda of 1731 cases. Ann Vasc Surg. 2013;27(4):447-53. http://dx.doi. org/10.1016/j.avsg.2012.05.026. PMid:23406790.

17. Lyra R M, Campos JR, Kang DW, et al. Guidelines for the prevention, diagnosis and treatment of compensatory hyperhidrosis. J Bras Pneumol. 2008;34(11):967-77. PMid:19099105.

18. Campos JRM, Wolosker N, Takeda FR, et al. The body mass index and level of resection: predictive factors for compensatory sweating after sympathectomy. Clin Auton Res. 2005;15(2):116-20. http:// dx.doi.org/10.1007/s10286-005-0259-6. PMid:15834768.

19. Sugimura H, Spratt EH, Compeau CG, Kattail D, Shargall Y. Thoracoscopic sympathetic clipping for hyperhidrosis: long-term results and reversibility. J Thorac Cardiovasc Surg. 2009;137(6):1370- 6. http://dx.doi.org/10.1016/j.jtcvs.2009.01.008. PMid:19464450.

20. Haam SJ, Park SY, Paik HC, Lee DY. Sympathetic nerve reconstruction for compensatory hyperhidrosis after sympathetic surgery for primary hyperhidrosis. J Korean Med Sci. 2010;25(4):597-601. http://dx.doi.org/10.3346/jkms.2010.25.4.597. PMid:20358004.

21. Teivelis MP, Wolosker N, Krutman M, Campos JRM, Kauffman P, Puech-Leão P. Compensatory hyperhidrosis: results of pharmacologic treatment with oxybutynin. Ann Thorac Surg. 2014;98(5):1797-802. http://dx.doi.org/10.1016/j.athoracsur.2014.05.087. PMid:25173719.

22. Kao MC. Thoracoscopic sympathectomy for craniofacial hyperhidrosis. Eur J Cardiothorac Surg. 2001;19(6):951-2. http:// dx.doi.org/10.1016/S1010-7940(01)00729-1. PMid:11482300.

23. Ishy A, Campos JRM, Wolosker N, et al. Objective evaluation of patients with palmar hyperhidrosis submitted to two levels of sympathectomy: T3 and T4. Interact Cardiovasc Thorac Surg. 2011;12(4):545-8. http://dx.doi.org/10.1510/icvts.2010.252015. PMid:21233258.

24. Munia MAS, Wolosker N, Kaufmann P, Campos JRM, PuechLeão P. Sustained benefit lasting one year from T4 instead of T3-T4 sympathectomy for isolated axillary hyperhidrosis. Clinics. 2008;63(6):771-4. http://dx.doi.org/10.1590/S1807-59322008000600011. PMid:19060999.

Sociedade Brasileira de Angiologia e Cirurgia Vascular (SBACV)"> Sociedade Brasileira de Angiologia e Cirurgia Vascular (SBACV)">
5dded3610e8825f6537279a1 jvb Articles

J Vasc Bras

Share this page
Page Sections